Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.64 |
| ▸ | MEN1 | O00255 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.57 |
| ▸ | F2 | P00734 | 3/20 | 0.55 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.55 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.55 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | HGFAC | Q04756 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.51 |
| ▸ | MLNR | O43193 | 1/20 | 0.51 |
| ▸ | C1R | P00736 | 1/20 | 0.51 |
| ▸ | F10 | P00742 | 1/20 | 0.51 |
| ▸ | PLG | P00747 | 1/20 | 0.51 |
| ▸ | F12 | P00748 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5710317 | 0.93 | KMT2A (0.75) | KMT2AMEN1MAPTTDP1NR1H4 | |
| SCHEMBL6052916 | 0.88 | KMT2A (0.58) | KMT2AMEN1MAPTTDP1NR1H4 | |
| SCHEMBL4132832 | 0.87 | KMT2A (0.57) | KMT2AMEN1MAPTTDP1NR1H4 | |
| SCHEMBL13292774 | 0.86 | KMT2A (0.59) | KMT2AMEN1MAPTTDP1NR1H4 | |
| SCHEMBL7342376 | 0.85 | F12 (0.71) | KMT2AMEN1MAPTTDP1NR1H4 | |
| SCHEMBL9788371 | 0.85 | F2 (0.58) | KMT2AMEN1MAPTTDP1NR1H4 | |
| SCHEMBL346698 | 0.85 | PRSS1 (0.71) | KMT2AMEN1NR1H4F2PRSS1 | |
| SCHEMBL107649 | 0.85 | PRSS1 (0.71) | KMT2AMEN1NR1H4F2PRSS1 | |
| SCHEMBL347429 | 0.85 | PRSS1 (0.71) | KMT2AMEN1NR1H4F2PRSS1 | |
| SCHEMBL11649516 | 0.83 | KMT2A (0.60) | KMT2AMEN1MAPTTDP1NR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130203895-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130203895-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-20130012620-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| US-20130012620-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| US-8288591-B2 | Curing agents for epoxy resins | DESIGNER MOLECULES, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| US-8288591-B2 | Curing agents for epoxy resins | DESIGNER MOLECULES, INC. (US) | 2012-10-16 | — | — | US | disclosed |
| US-20100144977-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2010-06-10 | — | — | US | disclosed |
| US-20100144977-A1 | CURING AGENTS FOR EPOXY RESINS | DESIGNER MOLECULES, INC. (US) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012620-A1 | CURING AGENTS FOR EPOXY RESINS | DOT1L, EHMT1, ASH1L | KMT2A 271/4885MEN1 3864/4885MAPT 1749/4885 |
| US-20100144977-A1 | CURING AGENTS FOR EPOXY RESINS | PTGER3, PTGER4, ELL | KMT2A 669/4885MEN1 3568/4885MAPT 3745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.